Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background To report a single institutional experience with definitive radiation therapy alone for human papillomavirus (HPV)-positive head and neck cancer. Methods A total of 67 patients were treated by radiation therapy alone to a median dose of 70 Gy (range, 66-72 Gy) for squamous cell carcinoma of the head and neck. Paraffin-embedded, formalin-fixed pretreatment tumor tissues were used to establish HPV-positivity using standardized techniques of immunohistochemistry for p16 and polymerase chain reaction for HPV. Results In all, 23 patients with HPV-positive cancers were identified. With a median follow-up of 28 months (range, 6-85 months), the 3-year actuarial rates of overall survival, locoregional control, and distant metastasis-free survival were 83%, 90%, and 88%, respectively. Conclusion These findings attest to the exquisite radiosensitivity of HPV-positive head and neck cancer. The clinical outcomes observed from this selected series compare favorably with historical controls treated by more intensive chemoradiotherapy strategies.

Original languageEnglish (US)
Pages (from-to)1652-1656
Number of pages5
JournalHead and Neck
Volume35
Issue number11
DOIs
StatePublished - 2013

Fingerprint

Head and Neck Neoplasms
Radiotherapy
Drug Therapy
Radiation Tolerance
Chemoradiotherapy
Paraffin
Formaldehyde
Neoplasms
Survival Rate
Immunohistochemistry
Neoplasm Metastasis
Polymerase Chain Reaction
Survival

Keywords

  • head and neck cancer
  • human papillomavirus
  • radiation therapy
  • radiosensitivity
  • squamous cell carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer. / Chen, Allen M.; Zahra, Talia; Daly, Megan E; Farwell, D Gregory; Luu, Quang; Gandour-Edwards, Regina F; Vaughan, Andrew T M.

In: Head and Neck, Vol. 35, No. 11, 2013, p. 1652-1656.

Research output: Contribution to journalArticle

@article{e3836dc6efa84e7ea5a277f406176c05,
title = "Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer",
abstract = "Background To report a single institutional experience with definitive radiation therapy alone for human papillomavirus (HPV)-positive head and neck cancer. Methods A total of 67 patients were treated by radiation therapy alone to a median dose of 70 Gy (range, 66-72 Gy) for squamous cell carcinoma of the head and neck. Paraffin-embedded, formalin-fixed pretreatment tumor tissues were used to establish HPV-positivity using standardized techniques of immunohistochemistry for p16 and polymerase chain reaction for HPV. Results In all, 23 patients with HPV-positive cancers were identified. With a median follow-up of 28 months (range, 6-85 months), the 3-year actuarial rates of overall survival, locoregional control, and distant metastasis-free survival were 83{\%}, 90{\%}, and 88{\%}, respectively. Conclusion These findings attest to the exquisite radiosensitivity of HPV-positive head and neck cancer. The clinical outcomes observed from this selected series compare favorably with historical controls treated by more intensive chemoradiotherapy strategies.",
keywords = "head and neck cancer, human papillomavirus, radiation therapy, radiosensitivity, squamous cell carcinoma",
author = "Chen, {Allen M.} and Talia Zahra and Daly, {Megan E} and Farwell, {D Gregory} and Quang Luu and Gandour-Edwards, {Regina F} and Vaughan, {Andrew T M}",
year = "2013",
doi = "10.1002/hed.23209",
language = "English (US)",
volume = "35",
pages = "1652--1656",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer

AU - Chen, Allen M.

AU - Zahra, Talia

AU - Daly, Megan E

AU - Farwell, D Gregory

AU - Luu, Quang

AU - Gandour-Edwards, Regina F

AU - Vaughan, Andrew T M

PY - 2013

Y1 - 2013

N2 - Background To report a single institutional experience with definitive radiation therapy alone for human papillomavirus (HPV)-positive head and neck cancer. Methods A total of 67 patients were treated by radiation therapy alone to a median dose of 70 Gy (range, 66-72 Gy) for squamous cell carcinoma of the head and neck. Paraffin-embedded, formalin-fixed pretreatment tumor tissues were used to establish HPV-positivity using standardized techniques of immunohistochemistry for p16 and polymerase chain reaction for HPV. Results In all, 23 patients with HPV-positive cancers were identified. With a median follow-up of 28 months (range, 6-85 months), the 3-year actuarial rates of overall survival, locoregional control, and distant metastasis-free survival were 83%, 90%, and 88%, respectively. Conclusion These findings attest to the exquisite radiosensitivity of HPV-positive head and neck cancer. The clinical outcomes observed from this selected series compare favorably with historical controls treated by more intensive chemoradiotherapy strategies.

AB - Background To report a single institutional experience with definitive radiation therapy alone for human papillomavirus (HPV)-positive head and neck cancer. Methods A total of 67 patients were treated by radiation therapy alone to a median dose of 70 Gy (range, 66-72 Gy) for squamous cell carcinoma of the head and neck. Paraffin-embedded, formalin-fixed pretreatment tumor tissues were used to establish HPV-positivity using standardized techniques of immunohistochemistry for p16 and polymerase chain reaction for HPV. Results In all, 23 patients with HPV-positive cancers were identified. With a median follow-up of 28 months (range, 6-85 months), the 3-year actuarial rates of overall survival, locoregional control, and distant metastasis-free survival were 83%, 90%, and 88%, respectively. Conclusion These findings attest to the exquisite radiosensitivity of HPV-positive head and neck cancer. The clinical outcomes observed from this selected series compare favorably with historical controls treated by more intensive chemoradiotherapy strategies.

KW - head and neck cancer

KW - human papillomavirus

KW - radiation therapy

KW - radiosensitivity

KW - squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84886432461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886432461&partnerID=8YFLogxK

U2 - 10.1002/hed.23209

DO - 10.1002/hed.23209

M3 - Article

C2 - 23335285

AN - SCOPUS:84886432461

VL - 35

SP - 1652

EP - 1656

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 11

ER -